2011
DOI: 10.1021/jm200592f
|View full text |Cite
|
Sign up to set email alerts
|

Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential

Abstract: Drug therapy is the mainstay of antimalarial therapy, yet current drugs are threatened by the development of resistance. In an effort to identify new potential anti-malarials we have undertaken a lead optimization program around our previously identified triazolopyrimidine-based series of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors. The X-ray structure of PfDHODH was used to inform the medicinal chemistry program allowing the identification of a potent and selective inhibitor (DSM26… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

7
336
3
2

Year Published

2012
2012
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 260 publications
(348 citation statements)
references
References 43 publications
7
336
3
2
Order By: Relevance
“…Key hydrogen-bond contacts used by the triazolopyrimidines and other chemical series are the amino acid residues Arg-265 and His-185, highlighted in Figure 4A. Two inhibitor classes have been crystallised with PfDHODH to date: the aforementioned triazolopyrimidines (PDB ID 3SFK) [59] and the thiophene-2-carboxamides (PDB ID 3O8A) [60], The structures reveal that the inhibitor binding pocket is directly adjacent to the FMN cofactor (shown in red in Fig. 4A) which can be divided into two portions: (i) the space immediately next to the FMN which is generally fully occupied by structurally-diverse PfDHODH inhibitors (i.e.…”
Section: Dhodh -Targeting Pyrimidine Biosynthesis Using Structure-basmentioning
confidence: 99%
“…Key hydrogen-bond contacts used by the triazolopyrimidines and other chemical series are the amino acid residues Arg-265 and His-185, highlighted in Figure 4A. Two inhibitor classes have been crystallised with PfDHODH to date: the aforementioned triazolopyrimidines (PDB ID 3SFK) [59] and the thiophene-2-carboxamides (PDB ID 3O8A) [60], The structures reveal that the inhibitor binding pocket is directly adjacent to the FMN cofactor (shown in red in Fig. 4A) which can be divided into two portions: (i) the space immediately next to the FMN which is generally fully occupied by structurally-diverse PfDHODH inhibitors (i.e.…”
Section: Dhodh -Targeting Pyrimidine Biosynthesis Using Structure-basmentioning
confidence: 99%
“…The compounds above were subsequently optimised and a number of novel derivatives having the structure below where synthesised and tested for their ability to inhibit P. falciparum and P. berghei DHODH [122]. The compounds having R = CF 2 CH 3 were found to display the highest inhibitory potency and the DHODH/CF 3 -triazolopyrimidine complex was successfully crystallised confirming that the CF 3 group (and therefore the SF 5 group too) occupy a narrow and hydrophobic pocket of the enzyme.…”
Section: Figurementioning
confidence: 99%
“…see Refs. [7][8][9][10][11][12]. The challenge to develop selective agents with targeted approaches has been a formidable obstacle to overcome in bringing such agents to the clinic.…”
mentioning
confidence: 99%
“…Although elements of cell division have been and continue to be probed for antimalarial potential, including DNA replication (10,11,15,16) and microtubule assembly and function (17)(18)(19), specific mitotic targets have not been validated in Plasmodium heretofore. The essential and conserved roles of mitotic enzymes in all eukaryotes argue for the directed development of this class of novel antimalarial candidates.…”
mentioning
confidence: 99%